Seegene, a global molecular diagnostics company, has introduced STAgora™, a real-time data analytics platform based on aggregated statistical testing data, and presented an enhanced model of its automated PCR workflow concept CURECA™ at ESCMID Global 2026 (formerly ECCMID), held April 17–21 in Munich, Germany, drawing interest from healthcare professionals attending the event.
“STAgora is designed to connect PCR testing data generated around the world in real time and provide a clearer view of infectious disease trends based on aggregated statistics,” said Young Seag Baeg, New Business Officer at Seegene. “We are continuing to explore how real-time data analytics, combined with automated testing infrastructure, can help laboratories better understand infection patterns and expand the practical use of aggregated testing data.”
A clinician from a university hospital in Germany who experienced the STAgora demonstration commented that the platform provided a more intuitive way to explore and visualise aggregated testing data trends. The clinician noted that the ability to view regional infection trends alongside aggregated test results in real time was particularly impactful.
“Interest in STAgora’s real-time data capabilities and practical applications was strong throughout the event,” said Daniel Shin, Executive Vice President and Chief Global Sales and Marketing Officer at Seegene. “We plan to expand pilot programmes and collaborative evaluations with healthcare and laboratory institutions to further evaluate the platform and support its potential future adoption.”
Seegene stated that it plans to further expand collaboration with clinical, academic, and research partners to support the implementation and validation of its data-driven diagnostics platform, with the goal of accelerating real-world adoption across global healthcare settings.
